{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:03Z","timestamp":1788539043760,"version":"build-2803163510"},"reference-count":222,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115142","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:22:48Z","timestamp":1785280968000},"page":"115142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy"],"prefix":"10.1016","volume":"462","author":[{"given":"Amr Ali Mohamed","family":"Abdelgawwad El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-7074","authenticated-orcid":false,"given":"Usamah","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslonov","family":"Farrukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtariy Mukhaydinovna","family":"Juraeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdusamiyeva","family":"Nargiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urazbaeva","family":"Yulduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shefali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12943-025-02480-x","article-title":"Reversal of tumour immune evasion via enhanced MHC-Class-I antigen presentation by a dual-functional RNA regulated system","volume":"24","author":"Meng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115142_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012435","article-title":"Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevance","volume":"13","author":"Sewastianik","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-024-01618-6","article-title":"NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.7150\/ijbs.92988","article-title":"The burgeoning significance of liquid-liquid phase separation in the pathogenesis and therapeutics of cancers","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib5","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1038\/s41467-025-59490-y","article-title":"Rational development of gemcitabine-based nanoplatform for targeting SERPINB9\/Granzyme B axis to overcome chemo-immune-resistance","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2526444","article-title":"Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapies","volume":"14","author":"Hutter-Karakoc","year":"2025","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexcr.2026.115142_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"49","key":"10.1016\/j.yexcr.2026.115142_bib8","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","article-title":"Mesenchymal stromal cells as cancer promoters","volume":"43","author":"Antoon","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/s42003-025-09087-4","article-title":"Fibroblast TGF-\u03b2 signaling defines spatial tumor ecosystems linked to immune checkpoint blockade resistance","volume":"8","author":"Lee","year":"2025","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib10","article-title":"Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1\u03b1 and tumor progression of clear cell ovarian cancer","volume":"5","author":"Mori","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1609479","article-title":"NK cell activity in the tumor microenvironment","volume":"13","author":"Kuznetsova","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115142_bib12","article-title":"The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer","volume":"15","author":"Pounds","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/0008-5472.CAN-24-1509","article-title":"Spatial and single-cell analyses reveal heterogeneity of DNAM-1 receptor-ligand interactions that instructs intratumoral \u03b3\u03b4T-cell activity","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115142_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.34133\/research.0948","article-title":"Chronic psychological stress in oncogenesis: multisystem crosstalk and multimodal interventions","volume":"8","author":"Huang","year":"2025","journal-title":"Research"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-025-02524-0","article-title":"Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors","volume":"10","author":"An","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12964-024-01894-2","article-title":"Trogocytosis in CAR immune cell therapy: a key mechanism of tumor immune escape","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115142_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13727","article-title":"Mesothelin CAR-engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals","volume":"57","author":"Liu","year":"2024","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41467-024-55770-1","article-title":"Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","volume":"16","author":"Pierini","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/biomedicines12010196","article-title":"The human soluble NKG2D ligand differentially impacts tumorigenicity and progression in temporal and model-dependent modes","volume":"12","author":"Serritella","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2026.115142_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1615760","article-title":"Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review","volume":"16","author":"Morva","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","article-title":"Engineered mesenchymal stem\/stromal cells against cancer","volume":"16","author":"Shi","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02770-1","article-title":"Author correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape","volume":"30","author":"Li","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319254121","article-title":"Fatty acid oxidation fuels natural killer cell responses against infection and cancer","volume":"121","author":"Sheppard","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib25","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11523-026-01220-5","article-title":"Therapeutic strategies targeting the tumor\u2013stromal microenvironment in colorectal cancer: a narrative review","volume":"21","author":"Heilijgers","year":"2026","journal-title":"Targeted Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101985","article-title":"Engineering approaches for studying immune-tumor cell interactions and immunotherapy","volume":"24","author":"Shelton","year":"2021","journal-title":"iScience"},{"issue":"47","key":"10.1016\/j.yexcr.2026.115142_bib30","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1073\/pnas.1508520112","article-title":"Regenerative medicine: current therapies and future directions","volume":"112","author":"Mao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"32","key":"10.1016\/j.yexcr.2026.115142_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202502880","article-title":"Double cross\u2010linked hydrogel for intra\u2010articular injection as modality for macrophages metabolic reprogramming and therapy of rheumatoid arthritis","volume":"35","author":"Song","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.yexcr.2026.115142_bib32","doi-asserted-by":"crossref","first-page":"rbag033","DOI":"10.1093\/rb\/rbag033","article-title":"Targeting delayed healing tissues: immune reprogramming of adaptive immune cells by biomaterials","volume":"13","author":"Wu","year":"2026","journal-title":"Regen. Biomater."},{"issue":"24","key":"10.1016\/j.yexcr.2026.115142_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30244808","article-title":"Mesenchymal stromal\/stem cells (MSCs) in cancer therapy: advanced therapeutic strategies towards future clinical translation","volume":"30","author":"Kucharczyk","year":"2025","journal-title":"Molecules"},{"issue":"48","key":"10.1016\/j.yexcr.2026.115142_bib34","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s43046-025-00334-7","article-title":"Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming","volume":"37","author":"Adusumalli","year":"2025","journal-title":"J. Egypt. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41419-026-08685-2","article-title":"Decoding the CAF\u2013TAM axis: multi-omics dissection and therapeutic targeting of stromal\u2013immune crosstalk in the tumor microenvironment","volume":"17","author":"Fu","year":"2026","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13046-025-03527-z","article-title":"Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115142_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101310","article-title":"From inflammation to malignancy: the dynamic evolution of cancer-associated fibroblasts in IBD-CRC","volume":"77","author":"Naito","year":"2026","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-026-00893-5","article-title":"Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer","volume":"12","author":"Ye","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.yexcr.2026.115142_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.167492","article-title":"Enhancing therapeutic potential of cellular hitchhiking through bioorthogonal chemistry","volume":"522","author":"Jia","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13287-025-04576-z","article-title":"Inflammatory cytokine-primed MSC-derived extracellular vesicles ameliorate acute lung injury via enhanced immunomodulation and alveolar repair","volume":"16","author":"Jeong","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxaf014","article-title":"Impact of pro-inflammatory cytokine preconditioning on metabolism and extracellular vesicles in feline mesenchymal stromal cells: a preliminary study","volume":"43","author":"Soltero-Rivera","year":"2025","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2026.115142_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217081","article-title":"Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity","volume":"597","author":"Qian","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.115142_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1010399","article-title":"Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells","volume":"13","author":"Sarsenova","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41392-025-02442-1","article-title":"Mesenchymal stromal cells induce neutrophil aggregation and extracellular vesicle storms for systemic lupus erythematosus","volume":"10","author":"Ou","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib47","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1165\/rcmb.2025-0398OC","article-title":"Specialized proresolving mediator-loaded extracellular vesicles mitigate pulmonary inflammation","volume":"74","author":"Karpurapu","year":"2026","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib48","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41467-025-57133-w","article-title":"Dual-mode action of scalable, high-quality engineered stem cell-derived SIRP\u03b1-extracellular vesicles for treating acute liver failure","volume":"16","author":"Kim","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115142_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100097","article-title":"Resolution pharmacology: state-of-the-art and therapeutic landscape","volume":"77","author":"Perretti","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2026.115142_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1473788","article-title":"Improving the therapeutic profile of MSCs: cytokine priming reduces donor-dependent heterogeneity and enhances their immunomodulatory capacity","volume":"16","author":"Valencia","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13287-025-04158-z","article-title":"Fate and long-lasting therapeutic effects of mesenchymal stromal\/stem-like cells: mechanistic insights","volume":"16","author":"Hoseinzadeh","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12896-025-01083-0","article-title":"Effects of optogenetic stimulation on neural gene expression in human bone marrow and adipose-derived mesenchymal stem cells","volume":"26","author":"Fereidounian","year":"2025","journal-title":"BMC Biotechnol."},{"issue":"21","key":"10.1016\/j.yexcr.2026.115142_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells14211660","article-title":"Safety assessment of stem cell-based therapies: current standards and advancing frameworks","volume":"14","author":"Leonov","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20517\/evcna.2025.84","article-title":"Priming strategies to enhance the therapeutic efficacy of mesenchymal stromal\/stem cell-derived vesicles in regenerative medicine","volume":"7","author":"Miceli","year":"2026","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"10.1016\/j.yexcr.2026.115142_bib55","article-title":"Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application","volume":"15","author":"Ren","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115142_bib56","article-title":"Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1738558","article-title":"Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy","volume":"16","author":"Cianga","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-025-03351-5","article-title":"A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells","volume":"44","author":"Yi","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"96","key":"10.1016\/j.yexcr.2026.115142_bib59","doi-asserted-by":"crossref","first-page":"eadk4893","DOI":"10.1126\/sciimmunol.adk4893","article-title":"Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation","volume":"9","author":"Foltz","year":"2024","journal-title":"Sci. Immunol."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154334","article-title":"Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse","volume":"132","author":"Shapiro","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2026.115142_bib61","article-title":"Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies","volume":"14","author":"He","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41590-025-02103-z","article-title":"Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGF\u03b2 and activin A suppression","volume":"26","author":"Rea","year":"2025","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib63","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220551","article-title":"Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting Fc\u03b5RI\u03b3 expression","volume":"219","author":"Shemesh","year":"2022","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib64","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/2326-6066.CIR-24-0852","article-title":"Adaptive NK cells exhibit tumor-specific immune memory and cytotoxicity in ovarian cancer","volume":"13","author":"Sun","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082323","article-title":"The function of NK cells in tumor metastasis and NK cell-based immunotherapy","volume":"15","author":"Yu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2026.115142_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2025.10.001","article-title":"Reprogramming natural killer cells in the tumor microenvironment: challenges and therapeutic opportunities","volume":"86","author":"Ma","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12935-025-03980-y","article-title":"The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies","volume":"25","author":"Zhu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2026.115142_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888313","article-title":"Plasticity of NK cells in cancer","volume":"13","author":"Corvino","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cytogfr.2025.10.009","article-title":"Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy","volume":"86","author":"Ma","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11033-025-11163-1","article-title":"Generation of the augmented IL-15-secreting anti-HER2 chimeric antigen receptor (CAR)-NK cells: an encouraging immunotherapeutic tool","volume":"53","author":"Darvishvand","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.yexcr.2026.115142_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115577","article-title":"Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells","volume":"166","author":"Feng","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib72","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.ymthe.2024.06.017","article-title":"Building a novel TRUCK by harnessing the endogenous IFN-gamma promoter for cytokine expression","volume":"32","author":"Ma","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-023-01894-9","article-title":"Outsmarting trogocytosis to boost CAR NK\/T cell therapy","volume":"22","author":"Ramezani","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.115142_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4598476","article-title":"Hypoxia impairs NK cell cytotoxicity through SHP-1-Mediated attenuation of STAT3 and ERK signaling pathways","volume":"2020","author":"Teng","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115142_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012988","article-title":"Colorectal cancer organoids drive hypoxia, TGF-\u03b2, and patient-specific diversification of NK cell activation programs","volume":"13","author":"von Kries","year":"2025","journal-title":"J. ImmunoTher. Cancer"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115142_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115800","article-title":"Distinct TAM subset with cross-dressing capability determines the bifurcation of tumor immunity","volume":"44","author":"Shimizu","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40164-024-00549-9","article-title":"The next frontier in immunotherapy: potential and challenges of CAR-macrophages","volume":"13","author":"Li","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115142_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36688","article-title":"Chimeric antigen receptors that trigger phagocytosis","volume":"7","author":"Morrissey","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.yexcr.2026.115142_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2026.105384","article-title":"Induced pluripotent stem cell (iPSC)-derived CAR-macrophages: new kids on the block","volume":"158","author":"Zhu","year":"2026","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.yexcr.2026.115142_bib81","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41551-025-01387-8","article-title":"Targeting inflammation with chimeric antigen receptor macrophages using a signal switch","volume":"9","author":"Cao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib82","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41467-018-04985-0","article-title":"Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway","volume":"9","author":"Tang-Huau","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib83","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-025-67674-9","article-title":"Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy","volume":"17","author":"Gu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib84","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/cancers12061411","article-title":"Transcriptional, epigenetic and metabolic programming of tumor-associated macrophages","volume":"12","author":"Larionova","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib85","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.celrep.2014.07.034","article-title":"IRF5:RelA interaction targets inflammatory genes in macrophages","volume":"8","author":"Saliba","year":"2014","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115142_bib86","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41590-026-02445-2","article-title":"Chemokine-defined macrophage niches establish spatial organization of tumor immunity","volume":"27","author":"Ghosh","year":"2026","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","article-title":"CAR-macrophages in solid tumors: promise, progress, and prospects","volume":"9","author":"Alrehaili","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib89","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","article-title":"Deep insight into cytokine storm: from pathogenesis to treatment","volume":"10","author":"Nie","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115142_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1518787","article-title":"Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy","volume":"16","author":"Krishnamoorthy","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40164-025-00725-5","article-title":"In vivo CAR-T cell engineering: concept, research progress, potential challenges and enhancement strategies","volume":"14","author":"Chen","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-026-01792-9","article-title":"Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies","volume":"19","author":"Chen","year":"2026","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib109","article-title":"Using the iCasp9 suicide strategy to control the growth and function of genome-edited B cells with redirected antigen specificity","volume":"33","author":"L\u00e9onard","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.yexcr.2026.115142_bib110","article-title":"Stealth designs to overcome allorejection in engineered cell therapy","volume":"1","author":"Li","year":"2026","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib111","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00018-025-05658-0","article-title":"R-spondins secreted by human pancreas-derived mesenchymal stromal cells support pancreatic organoid proliferation","volume":"82","author":"Cherubini","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib112","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/acssensors.4c01997","article-title":"SynNotch-Programmed macrophages for cancerous cell detection and sensing","volume":"9","author":"Wang","year":"2024","journal-title":"ACS Sens."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib93","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in clinical development of mesenchymal stromal\/stem cells: concise review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pharmthera.2019.04.005","article-title":"Mesenchymal stem cells: from regeneration to cancer","volume":"200","author":"Li","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115142_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/biom10121666","article-title":"Transforming growth Factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts","volume":"10","author":"Shi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2026.115142_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.587776","article-title":"Enhancement of the therapeutic capacity of mesenchymal stem cells by genetic modification: a systematic review","volume":"8","author":"Pawitan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40364-024-00637-2","article-title":"CAR macrophages: a promising novel immunotherapy for solid tumors and beyond","volume":"12","author":"Lu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.yexcr.2026.115142_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1658795","article-title":"Progress in targeting tumor-associated macrophages in cancer immunotherapy","volume":"16","author":"Xia","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib99","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s43556-025-00381-5","article-title":"Interferon signaling pathways in health and disease","volume":"6","author":"Wen","year":"2025","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43556-025-00401-4","article-title":"CAR-engineered cell therapies: current understandings and future perspectives","volume":"7","author":"Bayat","year":"2026","journal-title":"Molecular Biomedicine"},{"issue":"30","key":"10.1016\/j.yexcr.2026.115142_bib102","doi-asserted-by":"crossref","first-page":"eadd6997","DOI":"10.1126\/sciadv.add6997","article-title":"Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2026.115142_bib103","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-016-0098-2","article-title":"IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia","volume":"6","author":"Xu","year":"2016","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2026.115142_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.828875","article-title":"The effect of hypoxia and hypoxia-associated pathways in the regulation of antitumor response: friends or foes?","volume":"13","author":"Abou Khouzam","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41420-024-01815-9","article-title":"Breakthrough of solid tumor treatment: CAR-NK immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115142_bib107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179899","article-title":"CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in Lichen planus","volume":"9","author":"Kersh","year":"2024","journal-title":"JCI Insight"},{"issue":"46","key":"10.1016\/j.yexcr.2026.115142_bib108","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib113","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2509698123","article-title":"Lipid nanoparticle-mediated in vivo generation of panCAR immune cells for solid tumor immunotherapy","volume":"123","author":"Yin","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib114","article-title":"Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-025-01746-7","article-title":"Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution","volume":"18","author":"Chen","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08656-7","article-title":"Th17-driven CD8(+) T cells in hUC-MSC and CAR T-cell dual immunotherapy for superior anti-tumor efficacy","volume":"17","author":"Hu","year":"2026","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib117","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13287-024-03941-8","article-title":"Mesenchymal stem cell infusion for enhancing hematopoietic recovery and addressing cytopenias in CAR-T cell therapy","volume":"15","author":"Xia","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2026.115142_bib118","article-title":"Enhanced anti-tumor efficacy of \"IL-15 and CCL19\" -secreting CAR-T cells in human glioblastoma orthotopic xenograft model","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib119","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000582","article-title":"Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells","volume":"8","author":"Iida","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"17\u201318","key":"10.1016\/j.yexcr.2026.115142_bib120","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1089\/ten.tea.2017.0496","article-title":"Encapsulation of mesenchymal stem cells improves vascularization of alginate-based scaffolds","volume":"24","author":"Steiner","year":"2018","journal-title":"Tissue Eng Part A"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib121","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural killer cells at the frontline in the fight against cancer","volume":"15","author":"Co\u00ebnon","year":"2024","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib122","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10764","article-title":"The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration","volume":"7","author":"Gdynia","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib124","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1186\/s13287-025-04759-8","article-title":"Immunomodulatory and regenerative effects of human umbilical cord MSC-EVs in cutaneous leishmaniasis","volume":"16","author":"Borba","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12896-025-01024-x","article-title":"A novel feeder cell based on 4-1BBL and membrane-bound IL-21\/IL-15 induce highly expansion and anti-tumor effect of natural killer cells","volume":"25","author":"Gong","year":"2025","journal-title":"BMC Biotechnol."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib126","article-title":"Surface-engineered natural killer cell-derived small extracellular vesicles induce potent anti-tumour effects in lung cancer cells","volume":"4","author":"Kang","year":"2025","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.yexcr.2026.115142_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565696","article-title":"Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy","volume":"16","author":"Morisaki","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib128","article-title":"Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib129","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1038\/s41467-024-53996-7","article-title":"Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters","volume":"15","author":"Park","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-025-02386-8","article-title":"Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives","volume":"24","author":"Azeez","year":"2025","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32020079","article-title":"Tumor-associated extracellular matrix obstacles for CAR-T cell therapy: approaches to overcoming","volume":"32","author":"Klabukov","year":"2025","journal-title":"Curr. Oncol."},{"issue":"21","key":"10.1016\/j.yexcr.2026.115142_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213411","article-title":"Targeted hyaluronan degradation enhanced tumor growth inhibition in gastrointestinal cancer models","volume":"17","author":"Zhou","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib133","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1186\/s12967-025-07115-9","article-title":"New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M)","volume":"23","author":"Jing","year":"2025","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115142_bib134","article-title":"In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence","volume":"6","author":"Guo","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"3b","key":"10.1016\/j.yexcr.2026.115142_bib135","first-page":"1697","article-title":"uPA and uPAR contribute to NK cell invasion through the extracellular matrix","volume":"21","author":"Al-Atrash","year":"2001","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/bbrc.2002.6627","article-title":"IL-2-mediated upregulation of uPA and uPAR in natural killer cells","volume":"292","author":"Al-Atrash","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1712547","article-title":"Death as rebirth: how efferocytosis drives tissue repair and disease treatment","volume":"16","author":"Duan","year":"2026","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib138","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.7150\/thno.126081","article-title":"Targeting efferocytosis for tissue regeneration: from microenvironment reprogramming to clinical translation","volume":"16","author":"Li","year":"2026","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.yexcr.2026.115142_bib139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41419-024-06947-5","article-title":"Systemic mechanisms of necrotic cell debris clearance","volume":"15","author":"Schuermans","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12950-025-00470-w","article-title":"Glutaminase activity maintains NK cell cytotoxicity through metabolic regulation of effector function","volume":"22","author":"Jedli\u010dka","year":"2025","journal-title":"J. Inflamm."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib141","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101532","article-title":"Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis","volume":"63","author":"Taurino","year":"2022","journal-title":"Mol. Metabol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib143","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/SHK.0000000000002660","article-title":"Humanized MISTRG6 mice: a relevant translational model for examining early bone marrow changes in acute CLP sepsis","volume":"65","author":"Bielak","year":"2026","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12195-024-00817-y","article-title":"Multicompartmentalized microvascularized Tumor-on-a-Chip to study tumor-stroma interactions and drug resistance in ovarian cancer","volume":"17","author":"Plesselova","year":"2024","journal-title":"Cell. Mol. Bioeng."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/2767-9764.CRC-25-0193","article-title":"Ancestrally diverse autologous patient-derived organoid\u2013immune cell coculture platform for addressing immunotherapeutic outcome disparities in high-grade endometrial cancer","volume":"6","author":"Chung","year":"2026","journal-title":"Cancer Res. Commun."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115142_bib146","article-title":"Advanced human immune cell-organoid Co-Cultures for functional testing of cancer nanovaccines","volume":"13","author":"Ferreira","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib147","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41420-025-02505-w","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115142_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1712796","article-title":"My cells, my model: immune-competent autologous organ-on-chip systems as a new paradigm in precision medicine","volume":"16","author":"Bisconti","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib149","article-title":"Microfluidic engineering of immune-competent organs-on-chips and their applications","volume":"17","author":"Liang","year":"2026","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.yexcr.2026.115142_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70374","article-title":"Chimeric antigen receptor-macrophage therapy enters the clinic: the first-in-human trial for HER2(+) solid tumors","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm"},{"issue":"37","key":"10.1016\/j.yexcr.2026.115142_bib151","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306965120","article-title":"IL-6 trans-signaling in a humanized mouse model of scleroderma","volume":"120","author":"Odell","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115142_bib152","article-title":"Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1658795","article-title":"Progress in targeting tumor-associated macrophages in cancer immunotherapy","volume":"16","author":"Xia","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib154","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115142_bib155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.abst.2026.01.006","article-title":"Molecular imaging biomarkers of the tumour microenvironment: advances in early cancer detection and treatment response monitoring","volume":"8","author":"Rajendran","year":"2026","journal-title":"Adv. Biomarker Sci. Technol."},{"key":"10.1016\/j.yexcr.2026.115142_bib156","doi-asserted-by":"crossref","first-page":"e3593","DOI":"10.31661\/gmj.v14i.3593","article-title":"Comparison of the analgesic effect of ketamine and midazolam with paracetamol (Acetaminophen) and ketorolac in renal colic patients: a clinical trail","volume":"14","author":"Bahrami","year":"2025","journal-title":"Galen Medical Journal"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib157","first-page":"855","article-title":"Epidemiological study of aluminum phosphide poisoning mortality in tohid hospital, sanandaj, from 2010 to 2018","volume":"8","author":"Khedri","year":"2025","journal-title":"Journal of Iranian Medical Council"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib158","doi-asserted-by":"crossref","first-page":"220","DOI":"10.29252\/ajcm.26.4.220","article-title":"Study of the duration, outcomes, and related factors of reperfusion therapy in patients with ST-segment elevation myocardial infarction","volume":"26","author":"Rahimi","year":"2020","journal-title":"Avicenna J Clin Med"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43856-025-01336-1","article-title":"The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy","volume":"6","author":"Mekers","year":"2026","journal-title":"Communications Medicine"},{"key":"10.1016\/j.yexcr.2026.115142_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1612352","article-title":"Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications","volume":"16","author":"Shen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib161","article-title":"Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115142_bib162","article-title":"Evaluation of coagulation marker frequency and their relationship with disease severity in COVID-19 patients","volume":"15","author":"Ghaderi","year":"2025","journal-title":"Journal of Chemical Health Risks"},{"key":"10.1016\/j.yexcr.2026.115142_bib163","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jelectrocard.2023.02.002","article-title":"Association of electrocardiographic abnormalities and COVID-19 clinical outcomes","volume":"78","author":"Jabbari","year":"2023","journal-title":"J. Electrocardiol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib164","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12245-025-00913-4","article-title":"Epidemiological analysis of self-harm and suicide attempts in Iran: a cross-sectional study in Kurdistan's emergency hospitals","volume":"18","author":"Saedi","year":"2025","journal-title":"Int. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43045-024-00428-3","article-title":"Ketamine's efficacy in alleviating acute suicidal thoughts: a comprehensive systematic review and meta-analysis","volume":"31","author":"Seyedoshohadaei","year":"2024","journal-title":"Middle East Current Psychiatry"},{"key":"10.1016\/j.yexcr.2026.115142_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1677021","article-title":"Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs","volume":"12","author":"Huang","year":"2026","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102543","article-title":"Elimination of tumorigenic pluripotent stem cells from their differentiated cell therapy products: an important step toward ensuring safe cell therapy","volume":"20","author":"Movahed","year":"2025","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100185","article-title":"mRNA-based technology for engineered regenerative medicine","volume":"2","author":"Zhen","year":"2026","journal-title":"Cell Biomaterials"},{"key":"10.1016\/j.yexcr.2026.115142_bib169","doi-asserted-by":"crossref","first-page":"23","DOI":"10.34133\/cancomm.0023","article-title":"Harnessing the power of CAR-NK cells for solid tumors: challenges, innovations, and future frontiers in immunotherapy","volume":"46","author":"An","year":"2026","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-025-03558-6","article-title":"Challenges and opportunities of human iPSC-derived NK as \"Off-the-shelf\" cellular therapies","volume":"44","author":"Romanini","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115142_bib171","article-title":"CAR-M therapy in the era of tumor immunotherapy: current research progress and engineering strategies","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib172","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/14604086241257552","article-title":"Is admission neutrophil-to-lymphocyte ratio an outcome predictor in critically ill multiple trauma patients? A retrospective single-centre cross-sectional study","volume":"27","author":"Jabbari","year":"2025","journal-title":"Trauma"},{"key":"10.1016\/j.yexcr.2026.115142_bib173","first-page":"1","article-title":"CT distribution patterns of traumatic pneumothorax in blunt thoracic trauma: implications for targeted emergency imaging","author":"Jabbari","year":"2026","journal-title":"Emerg. Radiol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib174","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12877-026-07130-5","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of in-hospital mortality in elderly emergency patients: a retrospective study from southern Iran","volume":"26","author":"Jabbari","year":"2026","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13287-025-04471-7","article-title":"Engineering strategies to enhance the research progress of mesenchymal stem cells in wound healing","volume":"16","author":"Wang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2026.115142_bib176","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-4742-4_13","article-title":"mRNA-Based engineering of viral antigen-specific TCR-T cells","volume":"2965","author":"Shan","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"23_suppl","key":"10.1016\/j.yexcr.2026.115142_bib177","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.2024.42.23_suppl.37","article-title":"Hypoxia-responsive synthetic gene circuits to improve safety and potency of CAR T cell therapy for solid tumors","volume":"42","author":"Schreiber","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"47","key":"10.1016\/j.yexcr.2026.115142_bib178","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312374120","article-title":"Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy","volume":"120","author":"Bangayan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2026.115142_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1772146","article-title":"Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy","volume":"14","author":"Izumi","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"issue":"591","key":"10.1016\/j.yexcr.2026.115142_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675807","article-title":"Beyond CAR-T cells: exploring CAR-NK, CAR-M, and CAR-\u03b3\u03b4 T strategies in solid tumor immunotherapy","volume":"16","author":"Hou","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115142_bib182","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/14712598.2025.2601053","article-title":"Natural killer cell therapies in cancer: innovations, challenges, and future directions","volume":"25","author":"Aljabali","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib183","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4252\/wjsc.v7.i2.408","article-title":"Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?","volume":"7","author":"Arango-Rodriguez","year":"2015","journal-title":"World J Stem Cells"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib184","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","article-title":"Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications","volume":"25","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70292","article-title":"Cancer-associated fibroblasts: heterogeneity, cancer pathogenesis, and therapeutic targets","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"issue":"Suppl","key":"10.1016\/j.yexcr.2026.115142_bib186","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","article-title":"Sustained proliferation in cancer: mechanisms and novel therapeutic targets","volume":"35","author":"Feitelson","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib187","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib188","first-page":"265","article-title":"Multi-targeting CAR-T cell strategies to overcome immune evasion in lymphoid and myeloid malignancies","volume":"48","author":"Peter","year":"2025","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.yexcr.2026.115142_bib189","article-title":"Engineering macrophages via nanotechnology and genetic manipulation for cancer therapy","volume":"11","author":"Ding","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib190","first-page":"95","article-title":"The \"cytokine storm\" in infection and sepsis: win the battle but lose the war","volume":"12","author":"Fan","year":"2026","journal-title":"Mil Med Res"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115142_bib191","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41551-018-0246-6","article-title":"Biomanufacturing for clinically advanced cell therapies","volume":"2","author":"Aijaz","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"6622","key":"10.1016\/j.yexcr.2026.115142_bib192","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101487","article-title":"Comparison of NSG-Quad and MISTRG-6 humanized mice for modeling circulating and tumor-infiltrating human myeloid cells","volume":"33","author":"Chen","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.yexcr.2026.115142_bib194","series-title":"Considerations for the Design of Early-phase Clinical Trials of Cellular and Gene Therapy Products","year":"2015"},{"issue":"35","key":"10.1016\/j.yexcr.2026.115142_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202509638","article-title":"Engineered mesenchymal stem Cell\u2013NK cell complexes for spatially targeted and functionally revitalized cancer immunotherapy","volume":"13","author":"Zhang","year":"2026","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib196","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.yexcr.2026.115142_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02713683.2026.2691742","article-title":"LNP-delivered CAR-mRNA enables in vivo CAR-macrophage production for TYRP1-Targeted therapy of choroidal melanoma","author":"Chen","year":"2026","journal-title":"Curr. Eye Res."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib198","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/ijc.34468","article-title":"Tissue-resident CXCR4(+) macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression","volume":"152","author":"Liao","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib199","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-024-55137-6","article-title":"Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering","volume":"16","author":"Padilla","year":"2025","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.yexcr.2026.115142_bib200","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501190","article-title":"Lymphoid and CXCR4 cell targeted lipid nanoparticles facilitate HIV-1 proviral DNA excision","volume":"14","author":"Panja","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.yexcr.2026.115142_bib201","first-page":"pwaf058","article-title":"Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development, and precision medicine","author":"Li","year":"2025","journal-title":"Protein Cell"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115142_bib202","article-title":"Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip","volume":"5","author":"Veith","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41378-025-01068-1","article-title":"Single-cell-derived Tumor Organoid (STO) arrays on a microfluidic chip for personalized drug screening to address heterogeneity-induced drug resistance in colorectal cancer","volume":"11","author":"Lin","year":"2025","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.yexcr.2026.115142_bib204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/organoids4040023","article-title":"Organoids as next-generation models for tumor heterogeneity, personalized therapy, and cancer research: advancements, applications, and future directions","volume":"4","author":"Madan","year":"2025","journal-title":"Organoids"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115142_bib205","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","article-title":"Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.yexcr.2026.115142_bib206","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib207","article-title":"Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancer","volume":"7","author":"Zhang","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.yexcr.2026.115142_bib208","doi-asserted-by":"crossref","first-page":"279","DOI":"10.34133\/cbsystems.0279","article-title":"Skeletal muscle tissue engineering: from tissue regeneration to biorobotics","volume":"6","author":"Cordelle","year":"2025","journal-title":"Cyborg Bionic Syst"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib209","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41698-025-01243-7","article-title":"Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer","volume":"10","author":"Xie","year":"2026","journal-title":"npj Precis. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115142_bib210","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1021\/acs.biomac.4c01729","article-title":"Inhibiting friction-induced exogenous adhesion via robust lubricative core-shell nanofibers for high-quality tendon repair","volume":"26","author":"Cao","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.yexcr.2026.115142_bib211","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"43","key":"10.1016\/j.yexcr.2026.115142_bib212","article-title":"Blockade of CCR5(+) T cell accumulation in the tumor microenvironment optimizes Anti-TGF-\u03b2\/PD-L1 bispecific antibody","volume":"11","author":"Yi","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib213","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41467-026-69456-3","article-title":"Triple targeting of STING, TGF-\u03b2, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response","volume":"17","author":"Yi","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib214","article-title":"Recent advances in tumor immunotherapy based on NK cells","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41423-025-01297-4","article-title":"Adjusting the scope of natural killer cells in cancer therapy","volume":"22","author":"Shen","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.yexcr.2026.115142_bib216","doi-asserted-by":"crossref","first-page":"247","DOI":"10.34133\/cbsystems.0247","article-title":"Hollow mesoporous carbon nanospheres derived from metal-organic frameworks for efficient sono-immunotherapy against pancreatic cancer","volume":"6","author":"Chen","year":"2025","journal-title":"Cyborg Bionic Syst"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115142_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/cells15040373","article-title":"Engineering Bi-Specific CAR-NK cells to restore antibody-dependent cellular cytotoxicity in solid tumors","volume":"15","author":"Chung","year":"2026","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.yexcr.2026.115142_bib218","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011330","article-title":"Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy","volume":"13","author":"Reindl","year":"2025","journal-title":"J. ImmunoTher. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib219","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.reth.2025.04.014","article-title":"Preventing MSC aging and enhancing immunomodulation: novel strategies for cell-based therapies","volume":"29","author":"Elmi","year":"2025","journal-title":"Regen. Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115142_bib221","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1038\/s41467-025-59972-z","article-title":"CXCR4(+) mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115142_bib222","doi-asserted-by":"crossref","first-page":"468","DOI":"10.34133\/cbsystems.0468","article-title":"Reviving dormant immunity: millimeter waves reprogram the immunosuppressive microenvironment to potentiate immunotherapy without obvious side effects","volume":"6","author":"Jiang","year":"2025","journal-title":"Cyborg Bionic Syst"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:10:25Z","timestamp":1788538225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":222,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0014482726002594"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115142","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115142"}}